/West%20Pharmaceutical%20Services%2C%20Inc_%20phone%20and%20site-by%20T_Schneider%20via%20Shutterstock.jpg)
West Pharmaceutical Services, Inc. (WST) is a leading global manufacturer specializing in the design and production of advanced containment and delivery systems for injectable drugs and healthcare products. Valued at a market cap of $21.6 billion, the company offers solutions that meet the specific quality standards and product specifications required by customers worldwide. The company is expected to unveil its fiscal Q3 earnings results on Thursday, Oct. 24.
Prior to the event, analysts anticipate the medical device company to report a profit of $1.51 per share, down 30.1% from $2.16 per share in the year-ago quarter. The company has surpassed Wall Street's bottom-line estimates in three of the past four quarters while missing on one other occasion. In the last reported quarter, WST missed the consensus estimate by 14.1%.
